Clinical Trials
12 trialsNCT07454850 2026-05-18
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
Novartis
Not yet recruiting
NCT03934372 2026-04-16
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Phase 1/2 Recruiting
NCT03874858 2026-04-02
DANTE
Novartis
Phase 2 Completed
NCT05304377 2026-04-01
CML
Enliven Therapeutics
Phase 1 Recruiting
NCT07489755 2026-03-24
TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients
Shenzhen TargetRx Co., Ltd.
Phase 3 Not yet recruiting
NCT02467270 2026-03-17
OPTIC
Takeda
Phase 2 Completed
NCT07374120 2026-02-02
Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting
Novartis
Completed
NCT06163430 2026-01-12
CARDINAL
Terns, Inc.
Phase 1/2 Recruiting
NCT04666259 2025-10-16
AIM4CML
Novartis
Phase 3 Completed
NCT05384587 2025-10-14
ASC2ESCALATE
Novartis
Phase 2 Active not recruiting
NCT07091019 2025-07-29
ASC4REAL-2
Novartis
Not yet recruiting
NCT06787144 2025-07-01
CML
Enliven Therapeutics
Phase 1 Recruiting